KANSAS CITY -- ESPN reported that Royals veteran infielder Miguel Tejada, suspended last Saturday because of positive tests for amphetamine use, also was implicated in the Biogenesis investigation, but Major League Baseball issued a statement refuting the report.
"The Office of the Commissioner investigated all allegations regarding players associated with Anthony Bosch and Biogenesis. The investigation found no violation by Miguel Tejada of the Joint Drug Prevention and Treatment Program," the statement read.
Citing unnamed sources familiar with the case, ESPN's Pedro Gomez reported that Major League Baseball had the choice of penalizing Tejada in the Biogenesis case or for the amphetamine violation. Tejada was given the choice of a 105-game suspension for failed drug tests or facing additional punishment in the Biogenesis investigation, according to Gomez's sources.
MLB handed Tejada a 105-game suspension, which came six days after he went on the Royals' 60-day disabled list for a right calf injury.
The Biogenesis inquiry led to penalties on Aug. 5 for 13 players, including Alex Rodriguez, who appealed. The other 12 players accepted 50-game suspensions; Ryan Braun accepted a 65-game penalty on July 22.
Dick Kaegel is a reporter for MLB.com. This story was not subject to the approval of Major League Baseball or its clubs.